📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK (2024)

First Author: Dixon G

Attributed to: EPSRC Hub for Quantitative Modelling in Healthcare funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00529-2023

PubMed Identifier: 38226064

Publication URI: http://europepmc.org/abstract/MED/38226064

Type: Journal Article/Review

Parent Publication: ERJ Open Research

Issue: 1

ISSN: 2312-0541